51勛圖厙夥厙

Ralf Schmid

Ralf Schmid

Chief Financial Officer

Ralf Schmid is the Chief Financial Officer of 51勛圖厙夥厙. He brings more than 20 years of experience in M&A, licensing, and public and private market transactions in various leading positions in the fields of finance and administration in biotechnology and at several multinational companies, including Sandoz. Ralf joined 51勛圖厙夥厙 in 2016 from Nabriva Therapeutics AG, where he had served on the management board since the companys spin-off from Sandoz in 2006. In his role as Chief Financial Officer and Chief Operating Officer, Ralf was instrumental in taking the company public on Nasdaq in 2015.

Ralf holds a masters degree in finance and economics from Otto-Friedrich-Universit瓣t Bamberg, Germany.

Scroll to Top